You have a valid point, but you could also argue that interacting this way with specialist in the field might help PAR better understand the issues and obstacles to effective treatment, and that the more people in the 'industry' who know about us now, the easier and quicker the uptake will be when it hits the market.
You have a valid point, but you could also argue that...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.010(3.70%) |
Mkt cap ! $97.94M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.0¢ | 27.5¢ | $189.1K | 668.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 65071 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 16299 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.0¢ |
Change
0.010 ( 0.11 %) |
||||
| Open | High | Low | Volume | ||
| 28.5¢ | 29.0¢ | 27.5¢ | 246669 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| PAR (ASX) Chart |